The most common malignant diseases are presented separately on the website and in the FertiPROTEKT booklet. Due to the large number of even rarer malignant diseases, it is not possible to list all diseases individually and in detail. These include, for example, Ewing’s sarcoma, osteosarcoma, colon or rectal carcinoma, and also some rare leukemias and lymph node diseases. Since oncologic treatment in these cases is also accompanied by radiation and/or chemotherapy, ensuring fertility is also warranted in affected individuals. As in all other cases, the timing and choice of treatment methods depend on age, prognosis and the likelihood of a fertility-impairing effect of the therapy on the testes or ovaries.
One way to facilitate the patient’s decision after the consultation regarding fertility-preserving measures is the “Decision Aid” linked here. This digital decision aid has been developed by psychologists, psychotherapists and reproductive physicians and might help in an individual situation.
